Med Life SA (M) - Net Assets

Latest as of September 2025: RON502.03 Million RON ≈ $115.27 Million USD

Based on the latest financial reports, Med Life SA (M) has net assets worth RON502.03 Million RON (≈ $115.27 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RON3.14 Billion ≈ $721.65 Million USD) and total liabilities (RON2.64 Billion ≈ $606.38 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read total liabilities of Med Life SA for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	RON502.03 Million
% of Total Assets	15.97%
Annual Growth Rate	17.2%
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	16.68

Med Life SA - Net Assets Trend (2020–2024)

This chart illustrates how Med Life SA's net assets have evolved over time, based on quarterly financial data. Also explore M asset base for the complete picture of this company's asset base.

Annual Net Assets for Med Life SA (2020–2024)

The table below shows the annual net assets of Med Life SA from 2020 to 2024. For live valuation and market cap data, see market cap of Med Life SA.

Year	Net Assets	Change
2024-09-30	RON507.29 Million ≈ $116.48 Million	+2.65%
2023-09-30	RON494.19 Million ≈ $113.47 Million	+2.52%
2022-09-30	RON482.04 Million ≈ $110.68 Million	+26.39%
2021-09-30	RON381.40 Million ≈ $87.58 Million	+41.84%
2020-09-30	RON268.91 Million ≈ $61.75 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Med Life SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 104.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (September 2024)

Component	Amount	Percentage
Retained Earnings	RON72.92 Million	16.83%
Other Components	RON360.22 Million	83.17%
Total Equity	RON433.14 Million	100.00%

Med Life SA Competitors by Market Cap

The table below lists competitors of Med Life SA ranked by their market capitalization.

Company	Market Cap
Jiangsu Ankura Smart Transmission Engineering Technology Co Ltd SHE:300617	$1.46 Billion
SK IE Technology Co Ltd KO:361610	$1.46 Billion
Guangdong Orient Zirconic Ind Sci & Tech Co Ltd SHE:002167	$1.46 Billion
Chongqing Chuanyi Automation Co Ltd SHG:603100	$1.46 Billion
Fujian Qingshan Paper Industry Co Ltd SHG:600103	$1.46 Billion
Ningbo Sunrise Elc Technology Co Ltd Class A SHE:002937	$1.46 Billion
Fujian Expressway Development Co Ltd SHG:600033	$1.46 Billion
Jaiprakash Power Ventures Limited NSE:JPPOWER	$1.46 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Med Life SA's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 415,291,298 to 433,135,378, a change of 17,844,080 (4.3%).
Net income of 25,545,592 contributed positively to equity growth.
Share repurchases of 1,078,836 reduced equity.
Other factors decreased equity by 6,622,676.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	RON25.55 Million	+5.9%
Share Repurchases	RON1.08 Million	-0.25%
Other Changes	RON-6.62 Million	-1.53%
Total Change	RON-	4.30%

Book Value vs Market Value Analysis

This analysis compares Med Life SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 14.71x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 25.40x to 14.71x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2020-09-30	RON0.47	RON12.00	x
2021-09-30	RON0.66	RON12.00	x
2022-09-30	RON0.82	RON12.00	x
2023-09-30	RON0.79	RON12.00	x
2024-09-30	RON0.82	RON12.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Med Life SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 5.90%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.94%
• Asset Turnover: 0.90x
• Equity Multiplier: 6.98x
Recent ROE (5.90%) is below the historical average (13.67%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2020	23.50%	5.26%	0.91x	4.91x	RON32.58 Million
2021	30.35%	7.19%	1.01x	4.19x	RON68.80 Million
2022	7.72%	1.79%	0.83x	5.16x	RON-9.51 Million
2023	0.89%	0.17%	0.84x	6.35x	RON-37.84 Million
2024	5.90%	0.94%	0.90x	6.98x	RON-17.77 Million

Industry Comparison

This section compares Med Life SA's net assets metrics with peer companies in the Medical Care Facilities industry.

No peer company data available for comparison.

About Med Life SA

RO:M Romania Medical Care Facilities

Market Cap

$1.46 Billion

RON6.37 Billion RON

Market Cap Rank

#7490 Global

#10 in Romania

Share Price

RON12.00

Change (1 day)

-1.96%

52-Week Range

RON5.73 - RON14.28

All Time High

RON38.88